Abstract
Phenylketonuria (PKU) is one of the commonest inborn error of amino acid metabolism. Before mass neonatal screening was possible, and the success of introducing diet therapy right after birth, the typical clinical finds in patients ranged from intellectual disability, epilepsy, motor deficits to behavioral disturbances and other neurological and psychiatric symptoms. Since early diagnosis and treatment became widespread, usually only those patients who do not strictly follow the diet present psychiatric, less severe symptoms such as anxiety, depression, sleep pattern disturbance, and concentration and memory problems. Despite the success of low protein intake in preventing otherwise severe outcomes, PKU’s underlying neuropathophysiology remains to be better elucidated. Oxidative stress has gained acceptance as a disturbance implicated in the pathogenesis of PKU. The conception of oxidative stress has evolved to comprehend how it could interfere and ultimately modulate metabolic pathways regulating cell function. We summarize the evidence of oxidative damage, as well as compromised antioxidant defenses, from patients, animal models of PKU, and in vitro experiments, discussing the possible clinical significance of these findings. There are many studies on oxidative stress and PKU, but only a few went further than showing macromolecular damage and disturbance of antioxidant defenses. In this review, we argue that these few studies may point that oxidative stress may also disturb redox signaling in PKU, an aspect few authors have explored so far. The reported effect of phenylalanine on the expression or activity of enzymes participating in metabolic pathways known to be responsive to redox signaling might be mediated through oxidative stress.
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11011-021-00676-w/MediaObjects/11011_2021_676_Fig1_HTML.png)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11011-021-00676-w/MediaObjects/11011_2021_676_Fig2_HTML.png)
![](https://cdn.statically.io/img/media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11011-021-00676-w/MediaObjects/11011_2021_676_Fig3_HTML.png)
Similar content being viewed by others
Abbreviations
- ADMA:
-
asymmetric dimethylarginine
- CAT:
-
catalase
- Q10:
-
coenzyme ubiquinone-10
- ERK:
-
extracellular signal-regulated kinase
- ETC:
-
electron transport chain
- GPx:
-
glutathione peroxidase
- GSH:
-
reduced glutathione
- GSSG:
-
glutathione disulfide
- HPA:
-
hyperphenylalaninemia
- MAPK:
-
mitogen-activated protein kinase
- MDA:
-
malondialdehyde
- mtROS:
-
mitochondrial ROS
- NOS:
-
nitric oxide synthase
- Nrf2:
-
nuclear factor erythroid 2-related factor 2
- PAH:
-
phenylalanine hydroxylase
- Phe:
-
phenylalanine
- PKU:
-
phenylketonuria
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
- αMePhe:
-
α-methyl-L-phenylalanine
References
Anderson PJ, Leuzzi V (2010) White matter pathology in phenylketonuria. Mol Genet Metab 99(Suppl 1):S3–S9. https://doi.org/10.1016/j.ymgme.2009.10.005
Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J (1999) Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr 70:892–895. https://doi.org/10.1093/ajcn/70.5.892
Artuch R, Colome C, Vilaseca MA, Sierra C, Cambra FJ, Lambruschini N, Campistol J (2001) Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 24:359–366. https://doi.org/10.1023/a:1010500502275
Artuch R et al (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203. https://doi.org/10.1016/j.clinbiochem.2003.10.017
Azabdaftari A, van der Giet M, Schuchardt M, Hennermann JB, Plockinger U, Querfeld U (2019) The cardiovascular phenotype of adult patients with phenylketonuria. Orphanet J Rare Dis 14:213. https://doi.org/10.1186/s13023-019-1188-0
Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741–744. https://doi.org/10.1172/JCI107236
Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390:191–214. https://doi.org/10.1515/BC.2009.033
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313. https://doi.org/10.1152/physrev.00044.2005
Berti SL et al (2012) Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats. Metab Brain Dis 27:79–89. https://doi.org/10.1007/s11011-011-9271-9
Bilder DA, Burton BK, Coon H, Leviton L, Ashworth J, Lundy BD, Vespa H, Bakian AV, Longo N (2013) Psychiatric symptoms in adults with phenylketonuria. Mol Genet Metab 108(3):155–160
Bilder DA, Noel JK, Baker ER, Irish W, Chen Y, Merilainen MJ, Prasad S, Winslow BJ (2016) Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria. Dev Neuropsychol 41(4):245–260
Blasco H et al (2017) A multiplatform metabolomics approach to characterize plasma levels of phenylalanine and tyrosine in phenylketonuria. JIMD Rep 32:69–79. https://doi.org/10.1007/8904_2016_568
Blau N (2016) Genetics of phenylketonuria: then and now. Hum Mutat 37:508–515. https://doi.org/10.1002/humu.22980
Bone A, Kuehl AK, Angelino AF (2012) A neuropsychiatric perspective of phenylketonuria I: overview of phenylketonuria and its neuropsychiatric sequelae. Psychosomatics 53(6):517–523
Bortoluzzi VT, Brust L, Preissler T, de Franceschi ID, CMD W (2019) Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria. Metab Brain Dis 34:1649–1660. https://doi.org/10.1007/s11011-019-00472-7
Bulua AC, Simon A, Maddipati R, Pelletier M, Park H, Kim KY, Sack MN, Kastner DL, Siegel RM (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208(3):519–533
Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222–230
Cappelletti S, Cotugno G, Goffredo BM, Nicolò R, Bernabei SM, Caviglia S, di Ciommo V (2013) Cognitive findings and behavior in children and adolescents with phenylketonuria. J Dev Behav Pediatr 34(6):392–398
Castillo M, Zafra MF, Garcia-Peregrin E (1988) Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 13:551–555
Castillo M, Iglesias J, Zafra MF, Garcia-Peregrin E (1991a) Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem Int 18:171–174
Castillo M, Martinez-Cayuela M, Zafra MF, Garcia-Peregrin E (1991b) Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis. Mol Cell Biochem 105:21–25
Cervellini I, Galino J, Zhu N, Allen S, Birchmeier C, Bennett DL (2018) Sustained MAPK/ERK Activation in Adult Schwann Cells Impairs Nerve Repair. J Neurosci 38:679–690. https://doi.org/10.1523/JNEUROSCI.2255-17.2017
Chen H, Song YS, Chan PH (2009) Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab 29:1262–1272. https://doi.org/10.1038/jcbfm.2009.47
Cho HJ, Lee WH, Hwang OMH, Sonntag WE, Lee YW (2017) Role of NADPH oxidase in radiation-induced pro-oxidative and pro-inflammatory pathways in mouse brain. Int. J Radiat Biol 93:1257–1266. https://doi.org/10.1080/09553002.2017.1377360
Colome C et al (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35:81–84
Colome C et al (2003) Lipophilic antioxidants in patients with phenylketonuria. Am J Clin Nutr 77:185–188. https://doi.org/10.1093/ajcn/77.1.185
Deon M, Landgraf SS, Lamberty JF, Moura DJ, Saffi J, Wajner M, Vargas CR (2015a) Protective effect of L-carnitine on Phenylalanine-induced DNA damage. Metab Brain Dis 30:925–933. https://doi.org/10.1007/s11011-015-9649-1
Deon M et al (2015b) Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. Int J Dev Neurosci : The official J Int Soc Dev Neurosci 47:259–265. https://doi.org/10.1016/j.ijdevneu.2015.10.001
Deponte M (2013) Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes. Biochim Biophys Acta 1830:3217–3266. https://doi.org/10.1016/j.bbagen.2012.09.018
Di Meo S, Reed TT, Venditti P, Victor VM (2016) Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxidative Med Cell Longev 2016:1245049–1245044. https://doi.org/10.1155/2016/1245049
Dimer NW et al (2018) Brain bioenergetics in rats with acute hyperphenylalaninemia. Neurochem Int 117:188–203. https://doi.org/10.1016/j.neuint.2018.01.001
Di-Poi N, Faure J, Grizot S, Molnar G, Pick E, Dagher MC (2001) Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochem 40:10014–10022. https://doi.org/10.1021/bi010289c
Ekin S, Dogan M, Gok F, Karakus Y (2018) Assessment of antioxidant enzymes, total sialic acid, lipid bound sialic acid, vitamins and selected amino acids in children with phenylketonuria. Pediatr Res 84:821–828. https://doi.org/10.1038/s41390-018-0137-2
Ercal N, Aykin-Burns N, Gurer-Orhan H, JD MD (2002) Oxidative stress in a phenylketonuria animal model. Free Radic Biol Med 32:906–911. https://doi.org/10.1016/s0891-5849(02)00781-5
Ewald CY (2018) Redox signaling of NADPH oxidases regulates oxidative stress responses, Immun Aging Antioxidants 7 doi:https://doi.org/10.3390/antiox7100130
Fernandes CG et al (2010) Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell Mol Neurobiol 30:317–326. https://doi.org/10.1007/s10571-009-9455-6
Ficicioglu C et al (2013) A pilot study of Fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during Sapropterin supplementation. J Clin Neurol 9:151–156. https://doi.org/10.3988/jcn.2013.9.3.151
Fisberg RM, Da Silva-Femandes ME, Fisberg M, Schmidt BJ (1999) Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria. Nutr 15:449–452. https://doi.org/10.1016/s0899-9007(99)00082-9
Forman HJ (2016) Redox signaling: an evolution from free radicals to aging. Free Radic Biol Med 97:398–407. https://doi.org/10.1016/j.freeradbiomed.2016.07.003
Forman HJ, Cadenas E (2012) Oxidative stress and signal transduction. Springer Science & Business Media. https://doi.org/10.1007/978-1-4615-5981-8
Forman HJ, Zhang H, Rinna A (2009) Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Asp Med 30:1–12. https://doi.org/10.1016/j.mam.2008.08.006
Fu XJ, Peng YB, Hu YP, Shi YZ, Yao M, Zhang X (2014) NADPH oxidase 1 and its derived reactive oxygen species mediated tissue injury and repair. Oxidative Med Cell Longev 2014:282854. https://doi.org/10.1155/2014/282854
Gaesser JM, Fyffe-Maricich SL (2016) Intracellular signaling pathway regulation of myelination and remyelination in the CNS. Exp Neurol 283:501–511. https://doi.org/10.1016/j.expneurol.2016.03.008
Gassio R, Artuch R, Vilaseca MA, Fuste E, Colome R, Campistol J (2008) Cognitive functions and the antioxidant system in phenylketonuric patients. Neuropsychol 22:426–431. https://doi.org/10.1037/0894-4105.22.4.426
Gonzalez MJ et al (2011) Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Mol Genet Metab 104(Suppl):S73–S79
Guerra IMS, Ferreira HB, Neves B, Melo T, Diogo LM, Domingues MR, Moreira ASP (2020) Lipids and phenylketonuria: current evidences pointed the need for lipidomics studies. Arch Biochem Biophys 688:108431. https://doi.org/10.1016/j.abb.2020.108431
Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609–1623
Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724
Halliwell B (2007) Biochemistry of oxidative stress. Biochem Soc Trans 35:1147–1150. https://doi.org/10.1042/BST0351147
Hargreaves IP (2007) Coenzyme Q10 in phenylketonuria and mevalonic aciduria. Mitochondrion 7(Suppl):S175–S180. https://doi.org/10.1016/j.mito.2007.02.009
Hargreaves IP, Heales SJ, Briddon A, Land JM, Lee PJ (2002) Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis 25:673–679
Harraz MM et al (2008) SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118:659–670. https://doi.org/10.1172/JCI34060
Hartwig C, Gal A, Santer R, Ullrich K, Finckh U, Kreienkamp HJ (2006) Elevated phenylalanine levels interfere with neurite outgrowth stimulated by the neuronal cell adhesion molecule L1 in vitro. FEBS Lett 580(14):3489–3492
He Y, Gu X, Lu L, Liang L, Gao J, Zhang X (2013) NOX, the main regulator in oxidative stress in experimental models of phenylketonuria? J Pediatr Endocrinol Metab JPEM 26:675–682. https://doi.org/10.1515/jpem-2012-0387
He YZ, Gu XF, Lu LH, Liang LL (2014) The oxidative molecular regulation mechanism of NOX in children with phenylketonuria. Int J Dev Neurosci : The Official J Int Soc Deve Neurosci 38:178–183. https://doi.org/10.1016/j.ijdevneu.2014.09.002
Heasman SJ, Ridley AJ (2008) Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 9:690–701. https://doi.org/10.1038/nrm2476
Heo J, Campbell SL (2005) Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J Biol Chem 280:31003–31010. https://doi.org/10.1074/jbc.M504768200
Heo J, Raines KW, Mocanu V, Campbell SL (2006) Redox regulation of RhoA. Biochem 45:14481–14489. https://doi.org/10.1021/bi0610101
Hillert A et al (2020) The Genetic Landscape and Epidemiology of Phenylketonuria. Am J Hum Genet 107(2):234–250. https://doi.org/10.1016/j.ajhg.2020.06.006
Hobbs GA, Zhou B, Cox AD, Campbell SL (2014) Rho GTPases, oxidation, and cell redox control. small GTPases 5:e28579. https://doi.org/10.4161/sgtp.28579
Hommes FA, Moss L (1992) Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse. J Inherit Metab Dis 15:243–251
Hommes FA, Eller AG, Taylor EH (1982) Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria. J Inherit Metab Dis 5:21–27
Hordijk PL (2006) Regulation of NADPH oxidases: the role of Rac proteins. Circ Res 98:453–462. https://doi.org/10.1161/01.RES.0000204727.46710.5e
Horster F et al (2006) Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr Res 59(4 Pt 1):544–548
Huang WJ, Zhang X, Chen WW (2016) Role of oxidative stress in Alzheimer’s disease. Biomed Rep 4:519–522. https://doi.org/10.3892/br.2016.630
Huemer M et al (2012) Free asymmetric dimethylarginine (ADMA) is low in children and adolescents with classical phenylketonuria (PKU). J Inherit Metab Dis 35:817–821. https://doi.org/10.1007/s10545-011-9448-8
Huttenlocher PR (2000) The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 159(Suppl 2):S102–S106
Ishii A, Furusho M, Dupree JL, Bansal R (2016) Strength of ERK1/2 MAPK activation determines its effect on myelin and axonal integrity in the adult CNS. The J Neurosci : The Official J Soc Neurosci 36:6471–6487. https://doi.org/10.1523/JNEUROSCI.0299-16.2016
Item CB et al (2017) Demethylation of the promoter region of GPX3 in a newborn with classical phenylketonuria. Clin Biochem 50:159–161. https://doi.org/10.1016/j.clinbiochem.2016.10.001
Jochum F, Terwolbeck K, Meinhold H, Behne D, Menzel H, Lombeck I (1997) Effects of a low selenium state in patients with phenylketonuria. Acta Paediatr 86:775–777. https://doi.org/10.1111/j.1651-2227.1997.tb08587.x
Joseph B, Dyer CA (2003) Relationship between myelin production and dopamine synthesis in the PKU mouse brain. J Neurochem 86:615–626
Kayaalp E, Treacy E, Waters PJ, Byck S, Nowacki P, Scriver CR (1997) Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. Am J Hum Genet 61:1309–1317
Keshavarzi F, Rastegar M, Vessal M, Rafiei Dehbidi G, Khorsand M, Ganjkarimi AH, Takhshid MA (2018) Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria. Metab Brain Dis 33:675–680. https://doi.org/10.1007/s11011-017-0165-3
Kienzle Hagen ME et al (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Ac 1586:344–352. https://doi.org/10.1016/s0925-4439(01)00112-0
Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases: an update. Arch Toxicol 89:867–882. https://doi.org/10.1007/s00204-015-1472-2
Krämer J (2020) Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study. Mol Genet Metab Rep 22:100573. https://doi.org/10.1016/j.ymgmr.2020.100573
Kuiper JW, Sun C, Magalhaes MA, Glogauer M (2011) Rac regulates PtdInsP(3) signaling and the chemotactic compass through a redox-mediated feedback loop. Blood 118:6164–6171. https://doi.org/10.1182/blood-2010-09-310383
Kuksal N, Chalker J, Mailloux RJ (2017) Progress in understanding the molecular oxygen paradox - function of mitochondrial reactive oxygen species in cell signaling. Biol Chem 398:1209–1227. https://doi.org/10.1515/hsz-2017-0160
Kumru B, Kaplan DS, Ozturk Hismi B, Celik H (2018) Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients. Cell Mol Neurobiol 38:1033–1038. https://doi.org/10.1007/s10571-017-0573-2
Kumru B, Ozturk Hismi B, Kaplan DS, Celik H (2019) Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients. J Pediatr Endocrinol Metab : JPEM 32:269–274. https://doi.org/10.1515/jpem-2018-0454
Kyprianou N, Murphy E, Lee P, Hargreaves I (2009) Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia. J Inherit Metab Dis 32:289–296. https://doi.org/10.1007/s10545-009-1080-5
Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4:181–189. https://doi.org/10.1038/nri1312
Leuzzi V, Chiarotti F, Nardecchia F, van Vliet D, van Spronsen FJ (2020) Predictability and inconsistencies of cognitive outcome in patients with phenylketonuria and personalised therapy: the challenge for the future guidelines. J Med Genet 57(3):145–150. https://doi.org/10.1136/jmedgenet-2019-106278
Li D, Gu X, Lu L, Liang L (2010) Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor. Mol Cell Biochem 339:1–7. https://doi.org/10.1007/s11010-009-0364-2
Liu RM, Gaston Pravia KA (2010) Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med 48:1–15. https://doi.org/10.1016/j.freeradbiomed.2009.09.026
Lombeck I, Kasperek K, Feinendegen LE, Bremer HJ (1975) Serum-selenium concentrations in patients with maple-syrup-urine disease and phenylketonuria under dieto-therapy. Clinica chimica acta; Int J Clin Chem 64:57–61
Lombeck I, Kasperek K, Feinendegen LE, Bremer HJ (1978a) Trace element disturbances in dietetically treated patients with phenylketonuria and maple syrup urine disease. Monogr Hum Genet 9:114–117
Lombeck I, Kasperek K, Harbisch HD, Becker K, Schumann E, Schröter W, Feinendegen LE, Bremer HJ (1978b) The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease. Eur J Pediatr 128:213–223. https://doi.org/10.1007/bf00445606
Lombeck I, Jochum F, Terwolbeck K (1996) Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria. Eur J Pediatr 155(Suppl 1):S140–S144. https://doi.org/10.1007/pl00014232
Lu SC (2009) Regulation of glutathione synthesis. Mol Asp Med 30:42–59. https://doi.org/10.1016/j.mam.2008.05.005
Lu L, Gu X, Li D, Liang L, Zhao Z, Gao J (2011) Mechanisms regulating superoxide generation in experimental models of phenylketonuria: an essential role of NADPH oxidase. Mol Genet Metab 104:241–248. https://doi.org/10.1016/j.ymgme.2011.05.012
Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401–426. https://doi.org/10.1146/annurev-pharmtox-011112-140320
Ma MW, Wang J, Zhang Q, Wang R, Dhandapani KM, Vadlamudi RK, Brann DW (2017) NADPH oxidase in brain injury and neurodegenerative disorders. Mol Neurodegener 12:7. https://doi.org/10.1186/s13024-017-0150-7
Manara R, Burlina AP, Citton V, Ermani M, Vespignani F, Carollo C, Burlina AB (2009) Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria. Neuroradiol 51:803–812. https://doi.org/10.1007/s00234-009-0574-z
Margis R, Dunand C, Teixeira FK, Margis-Pinheiro M (2008) Glutathione peroxidase family - an evolutionary overview. FEBS J 275:3959–3970. https://doi.org/10.1111/j.1742-4658.2008.06542.x
Markesbery WR (1999) The role of oxidative stress in Alzheimer disease. Arch Neurol 56:1449–1452
Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Marchante C, Guerrero JM (2002) Oxidative stress induced by phenylketonuria in the rat: prevention by melatonin, vitamin E, and vitamin C. J Neurosci Res 69:550–558. https://doi.org/10.1002/jnr.10307
Martinez-Cruz F, Osuna C, Guerrero JM (2006) Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: its prevention by melatonin, Vitamin E, and Vitamin C. Neurosci Lett 392:1–4. https://doi.org/10.1016/j.neulet.2005.02.073
Martynyuk AE, Glushakov AV, Sumners C, Laipis PJ, Dennis DM, Seubert CN (2005) Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab 86(Suppl 1):S34–S42. https://doi.org/10.1016/j.ymgme.2005.06.014
Mazzola PN et al (2011) Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats. Metab Brain Dis 26:291–297. https://doi.org/10.1007/s11011-011-9264-8
Mazzola PN, Bruinenberg V, Anjema K, van Vliet D, Dutra-Filho CS, van Spronsen FJ, van der Zee EA (2016) Voluntary Exercise Prevents Oxidative Stress in the Brain of Phenylketonuria Mice. JIMD reports 27:69–77. https://doi.org/10.1007/8904_2015_498
Menzel H, Steiner G, Lombeck I, Ohnesorge FK (1983) Glutathione peroxidase and glutathione S-transferase activity of platelets. Eur J Pediatr 140:244–247
Mezzomo NJ et al (2019) Creatine nanoliposome reverts the HPA-induced damage in complex II-III activity of the rats’ cerebral cortex. Mol Biol Rep 46:5897–5908. https://doi.org/10.1007/s11033-019-05023-y
Mikoluc B et al (2012) Impact of lipophilic antioxidants and level of antibodies against oxidized low-density lipoprotein in polish children with phenylketonuria. Antioxid Redox Signal 16:179–182. https://doi.org/10.1089/ars.2011.4163
Moldogazieva NT, Mokhosoev IM, Feldman NB, Lutsenko SV (2018) ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications. Free Radic Res 52:507–543. https://doi.org/10.1080/10715762.2018.1457217
Moraes TB et al (2010) Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. J Neurol Sci 292:89–95. https://doi.org/10.1016/j.jns.2010.01.016
Moraes TB, Jacques CE, Rosa AP, Dalazen GR, Terra M, Coelho JG, Dutra-Filho CS (2013) Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid. Cell Mol Neurobiol 33:253–260. https://doi.org/10.1007/s10571-012-9892-5
Moraes TB, Dalazen GR, Jacques CE, de Freitas RS, Rosa AP, Dutra-Filho CS (2014) Glutathione metabolism enzymes in brain and liver of hyperphenylalaninemic rats and the effect of lipoic acid treatment. Metab Brain Dis 29:609–615. https://doi.org/10.1007/s11011-014-9491-x
Mori K, Shibanuma M, Nose K (2004) Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 64:7464–7472. https://doi.org/10.1158/0008-5472.CAN-04-1725
Nagasaka H et al (2013) Oxysterol changes along with cholesterol and vitamin D changes in adult phenylketonuric patients diagnosed by newborn mass-screening. Clinica chimica acta; Int J Clin Chem 416:54–59. https://doi.org/10.1016/j.cca.2012.10.011
Nagase M, Ayuzawa N, Kawarazaki W, Ishizawa K, Ueda K, Yoshida S, Fujita T (2012) Oxidative stress causes mineralocorticoid receptor activation in rat cardiomyocytes: role of small GTPase Rac1. Hypertens 59:500–506. https://doi.org/10.1161/HYPERTENSIONAHA.111.185520
Nathan C (2003) Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 111(6):769–778
Orr AL, Quinlan CL, Perevoshchikova IV, Brand MD (2012) A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J Biol Chem 287:42921–42935. https://doi.org/10.1074/jbc.M112.397828
Pallardo FV, Markovic J, Garcia JL, Vina J (2009) Role of nuclear glutathione as a key regulator of cell proliferation. Mol Asp Med 30:77–85. https://doi.org/10.1016/j.mam.2009.01.001
Park JW, Lee MH, Choi JO, Park HY, Jung SC (2010) Tissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid. Exp Mol Med 42:105–115. https://doi.org/10.3858/emm.2010.42.2.012
Parmeggiani B, Vargas CR (2018) Oxidative stress in urea cycle disorders: findings from clinical and basic research. Clinica chimica acta; Int J Clin Chem 477:121–126. https://doi.org/10.1016/j.cca.2017.11.041
Pascucci T et al (2018) A new therapy prevents intellectual disability in mouse with phenylketonuria. Mol Genet Metab 124:39–49. https://doi.org/10.1016/j.ymgme.2018.03.009
Pietz J, Rupp A, Ebinger F, Rating D, Mayatepek E, Boesch C, Kreis R (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654–662. https://doi.org/10.1203/01.PDR.0000055867.83310.9E
Preissler T et al (2016) Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria. Metab Brain Dis 31:529–537. https://doi.org/10.1007/s11011-015-9763-0
Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Orr AL, Brand MD (2013) Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol 1:304–312. https://doi.org/10.1016/j.redox.2013.04.005
Rani V, Deep G, Singh RK, Palle K, Yadav UC (2016) Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci 148:183–193. https://doi.org/10.1016/j.lfs.2016.02.002
Rausell D, Garcia-Blanco A, Correcher P, Vitoria I, Vento M, Chafer-Pericas C (2019) Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients. Pediatr Res 85:242–250. https://doi.org/10.1038/s41390-018-0202-x
Rech VC, Feksa LR, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2002) Inhibition of the mitochondrial respiratory chain by phenylalanine in rat cerebral cortex. Neurochem Res 27:353–357
Reddie KG, Carroll KS (2008) Expanding the functional diversity of proteins through cysteine oxidation. Curr Opin Chem Biol 12:746–754. https://doi.org/10.1016/j.cbpa.2008.07.028
Reilly C, Barrett JE, Patterson CM, Tinggi U, Latham SL, Marrinan A (1990) Trace element nutrition status and dietary intake of children with phenylketonuria. Am J Clin Nutr 52:159–165. https://doi.org/10.1093/ajcn/52.1.159
Rhee SG, Woo HA, Kil IS, Bae SH (2012) Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem 287:4403–4410. https://doi.org/10.1074/jbc.R111.283432
Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653–662. https://doi.org/10.1007/s10571-011-9693-2
Rocha JC, Martins MJ (2012) Oxidative stress in phenylketonuria: future directions. J Inherit Metab Dis 35:381–398. https://doi.org/10.1007/s10545-011-9417-2
Sabio G, Davis RJ (2014) TNF and MAP kinase signalling pathways. Semin Immunol 26:237–245. https://doi.org/10.1016/j.smim.2014.02.009
Sanayama Y et al (2011) Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab 103:220–225. https://doi.org/10.1016/j.ymgme.2011.03.019
Schoemans R et al (2010) Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites. J Inherit Metab Dis 33:113–120. https://doi.org/10.1007/s10545-010-9052-3
Schreibelt G et al (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21:3666–3676. https://doi.org/10.1096/fj.07-8329com
Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242. https://doi.org/10.1016/j.clinbiochem.2004.11.006
Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I (2007) Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet. Eur J Clin Nutr 61:803–808. https://doi.org/10.1038/sj.ejcn.1602591
Schulpis KH, Papastamataki M, Stamou H, Papassotiriou I, Margeli A (2010) The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Acta Paediatr 99:1565–1570. https://doi.org/10.1111/j.1651-2227.2010.01890.x
Schulpis KH, Kalogerakou M, Gioni V, Papastamataki M, Papassotiriou I (2011) Glutamine, ornithine, citrulline and arginine levels in children with phenylketonuria: the diet effect. Clin Biochem 44:821–825. https://doi.org/10.1016/j.clinbiochem.2011.05.002
Scriver CR (1995) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, Health Professions Division, New York
Selvakumar B, Hess DT, Goldschmidt-Clermont PJ, Stamler JS (2008) Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Lett 582:2195–2202. https://doi.org/10.1016/j.febslet.2008.04.062
Sierra C et al (1998) Antioxidant status in hyperphenylalaninemia. Clinica chimica acta; Int J Clin Chem 276:1–9. https://doi.org/10.1016/s0009-8981(98)00091-6
Sies H, Berndt C, Jones DP (2017) Oxidative Stress. Annu. Rev Biochem 86:715–748. https://doi.org/10.1146/annurev-biochem-061516-045037
Simon KR et al (2013) DNA damage induced by phenylalanine and its analogue p-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia. Biochem Cell Biol 91:319–324. https://doi.org/10.1139/bcb-2013-0023
Sirtori LR et al (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73. https://doi.org/10.1016/j.bbadis.2005.02.005
Sitta A et al (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296. https://doi.org/10.1007/s11011-006-9035-0
Sitta A et al. (2009a) Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients international journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 27:243-247 doi:https://doi.org/10.1016/j.ijdevneu.2009.01.001
Sitta A et al (2009b) L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211–218. https://doi.org/10.1007/s10571-008-9313-y
Sitta A, Manfredini V, Biasi L, Tremea R, Schwartz IV, Wajner M, Vargas CR (2009c) Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res 679:13–16. https://doi.org/10.1016/j.mrgentox.2009.07.013
Sitta A et al (2011) Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31:429–436. https://doi.org/10.1007/s10571-010-9636-3
Sosa V, Moline T, Somoza R, Paciucci R, Kondoh H, LL ME (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12:376–390. https://doi.org/10.1016/j.arr.2012.10.004
Spadaro D, Yun BW, Spoel SH, Chu C, Wang YQ, Loake GJ (2010) The redox switch: dynamic regulation of protein function by cysteine modifications. Physiol Plant 138:360–371. https://doi.org/10.1111/j.1399-3054.2009.01307.x
Steiner G, Menzel H, Lombeck I, Ohnesorge FK, Bremer HJ (1982) Plasma glutathione peroxidase after selenium supplementation in patients with reduced selenium state. Eur J Pediatr 138:138–140. https://doi.org/10.1007/bf00441140
Stepien KM, Heaton R, Rankin S, Murphy A, Bentley J, Sexton D, Hargreaves IP (2017) Evidence of Oxidative Stress and Secondary Mitochondrial Dysfunction in Metabolic and Non-Metabolic Disorders J Clin Med 6 doi:https://doi.org/10.3390/jcm6070071
Stocker S, Van Laer K, Mijuskovic A, Dick TP (2018) The Conundrum of Hydrogen Peroxide Signaling and the Emerging Role of Peroxiredoxins as Redox Relay Hubs. Antioxid Redox Signal 28:558–573. https://doi.org/10.1089/ars.2017.7162
St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD (2002) Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 277:44784–44790. https://doi.org/10.1074/jbc.M207217200
Suh YA et al (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nat 401:79–82. https://doi.org/10.1038/43459
Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159(Suppl 2):S109–S113
Suthanthiran M, Anderson ME, Sharma VK, Meister A (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci U S A 87:3343–3347. https://doi.org/10.1073/pnas.87.9.3343
Tavana S et al (2016) Prooxidant-antioxidant balance in patients with phenylketonuria and its correlation to biochemical and hematological parameters. J Pediatr Endocrinol Metab : JPEM 29:675–680. https://doi.org/10.1515/jpem-2015-0398
Torres M, Forman HJ (2003) Redox signaling and the MAP kinase pathways. BioFactors 17:287–296
Turrens JF, Boveris A (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191:421–427. https://doi.org/10.1042/bj1910421
Ursini F, Maiorino M, Forman HJ (2016) Redox homeostasis: The Golden Mean of healthy living. Redox Biol 8:205–215. https://doi.org/10.1016/j.redox.2016.01.010
van Bakel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981. https://doi.org/10.1093/ajcn/72.4.976
Veyrat-Durebex C et al (2017) Hyperphenylalaninemia correlated with global decrease of antioxidant genes expression in white blood cells of adult patients with phenylketonuria. JIMD reports 37:73–83. https://doi.org/10.1007/8904_2017_16
Vignais PV (2002) The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59:1428–1459
Wasserstein MP, Snyderman SE, Sansaricq C, Buchsbaum MS (2006) Cerebral glucose metabolism in adults with early treated classic phenylketonuria. Mol Genet Metab 87:272–277. https://doi.org/10.1016/j.ymgme.2005.06.010
Watson JN, Seagraves NJ (2019) RNA-Seq analysis in an avian model of maternal phenylketonuria. Mol Genet Metab 126:23–29. https://doi.org/10.1016/j.ymgme.2018.09.003
Werner E (2004) GTPases and reactive oxygen species: switches for killing and signaling. J Cell Sci 117:143–153. https://doi.org/10.1242/jcs.00937
Wilke BC, Vidailhet M, Favier A, Guillemin C, Ducros V, Arnaud J, Richard MJ (1992) Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation Clinica chimica acta; Int J Clin Chem 207:137-142 doi:https://doi.org/10.1016/0009-8981(92)90157-l
Wu DC, Teismann P, Tieu K, Vila M, Jackson-Lewis V, Ischiropoulos H, Przedborski S (2003) NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease. Proc Natl Acad Sci U S A 100:6145–6150. https://doi.org/10.1073/pnas.0937239100
Zekry D, Epperson TK, Krause KH (2003) A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia? IUBMB Life 55:307–313. https://doi.org/10.1080/1521654031000153049
Zhang H, Gu XF (2005) A study of gene expression profiles of cultured embryonic rat neurons induced by phenylalanine. Metab Brain Dis 20:61–72
Zhang Y, Zhang H, Yuan X, Gu X (2007) Differential effects of phenylalanine on Rac1, Cdc42, and RhoA expression and activity in cultured cortical neurons. Pediatr Res 62:8–13. https://doi.org/10.1203/PDR.0b013e31806772be
Zhang QG, Laird MD, Han D, Nguyen K, Scott E, Dong Y, Dhandapani KM, Brann DW (2012) Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. PloS one 7:e34504. https://doi.org/10.1371/journal.pone.0034504
Data availability statement
Not applicable
Funding
The authors would like to thank the Department of Biochemistry, the Institute of Basic Health Sciences of the Federal University of Rio Grande do Sul, and the funding agencies CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), and FINEP (Financiadora de Estudos e Projetos)- Rede Instituto Brasileiro de Neurociência.
Author information
Authors and Affiliations
Contributions
VB and CD independently screened the titles and abstracts and extracted data from the selected studies. VB wrote the manuscript and CD and CW revised it. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Not applicable.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
None declared.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bortoluzzi, V.T., Dutra Filho, C.S. & Wannmacher, C.M.D. Oxidative stress in phenylketonuria—evidence from human studies and animal models, and possible implications for redox signaling. Metab Brain Dis 36, 523–543 (2021). https://doi.org/10.1007/s11011-021-00676-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00676-w